Analyze Diet
Equine veterinary journal2018; 51(2); 238-245; doi: 10.1111/evj.13002

Pharmacokinetics of intravenous flumetasone and effects on plasma hydrocortisone concentrations and inflammatory mediators in the horse.

Abstract: Flumetasone is a potent corticosteroid reportedly used in horses to decrease inflammation associated with strenuous exercise. There are currently no reports describing the use of this drug in horses. Objective: To describe the pharmacokinetics and effects on cortisol and eicosanoid concentrations, following administration of flumetasone to exercised horses. Methods: Parallel design. Methods: Twelve exercised horses received a single i.v. administration of 5 mg of flumetasone. Blood and urine samples were collected before and for 72 h post-drug administration for determination of flumetasone and cortisol concentrations. Whole blood samples were collected at various time and challenged with lipopolysaccharide, calcium ionophore or methanol to induce ex vivo synthesis of eicosanoids. Concentrations of flumetasone, cortisol and eicosanoids were measured using LC-MS/MS and pharmacokinetic/pharmacodynamic analysis performed. Results: Flumetasone was detected for 23.5 ± 1.73 h in blood. The volume of distribution at steady state, systemic clearance and elimination half-life was 5.90 ± 0.200 L/kg, 30.7 ± 0.166 mL/min/kg and 4.84 ± 0.83 h respectively. Cortisol concentrations were still suppressed at last time point collected (72 h). For cortisol, K , K and the t were 30.3 ± 1.56 ng/mL × h, 0.331 ± 0.02 1/h and 2.1 h respectively. Stimulation with lipopolysaccharide resulted in a decrease in TXB , PGF , LTB , 15-HETE and 5-HETE for up to 72 h and PGE for 24 h post-flumetasone administration. Stimulation of whole blood with calcium ionophore resulted in a decrease in LTB for up to 6 h and 15-HETE at 8 h. Conclusions: Lack of sample collection for determination of biomarker concentrations beyond 72 h and the use of a single sample for determination of baseline cortisol concentrations. Conclusions: Flumetasone is rapidly cleared from blood following administration to horses. It is a potent anti-inflammatory with prolonged effects on production of cortisol and other inflammatory mediators.
Publication Date: 2018-09-03 PubMed ID: 30080272DOI: 10.1111/evj.13002Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research investigates the pharmacokinetics of flumetasone, a potent corticosteroid, in horses. It further examines the drug’s effects on cortisol and eicosanoid concentrations.

Research Methodology

  • The study utilized a parallel design in which twelve exercised horses were given a single intravenous (i.v.) dose of 5mg flumetasone.
  • Blood and urine samples were taken before and intermittently for 72 hours post-drug administration. These samples were used to measure concentrations of flumetasone and cortisol.
  • Through ex vivo synthesis, eicosanoid concentrations were determined. This process involved challenging whole blood samples, collected at various times, with lipopolysaccharide, calcium ionophore, or methanol.
  • All measurements were carried out using Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS) and pharmacokinetic/pharmacodynamic analysis.

Research Findings

  • The presence of flumetasone in the blood was observed for 23.5 ± 1.73 hours. This implicates the rapid clearance of the drug in the blood of horses.
  • Key parameters for flumetasone were: volume of distribution at steady-state (5.90 ± 0.200 L/kg), systemic clearance (30.7 ± 0.166 mL/min/kg), and elimination half-life (4.84 ± 0.83 hours).
  • Cortisol levels were observed to be suppressed up to the last collection point, 72 hours post-administration of the flumetasone.
  • Parameters for cortisol were also determined: K (30.3 ± 1.56 ng/mL × h), K (0.331 ± 0.02 1/h), and the t (2.1 hours).
  • The administration of flumetasone resulted in declines in specific eicosanoids, namely TXB, PGF, LTB, 15-HETE, and 5-HETE, up to 72 hours. It also influence the decrease in PGE up to 24 hours.

Conclusions

  • The constraints of the study included the limitation of biomarker concentration determination past 72 hours and the use of a single sample for determining baseline cortisol concentrations.
  • Despite these limitations, the use of flumetasone demonstrated rapid clearance from the blood once administered to the horses.
  • It was also identified that flumetasone has a strong anti-inflammatory effect with extended effects on the production of cortisol and other inflammatory mediators.

Cite This Article

APA
Knych HK, Arthur RM, McKemie DS, Baden R, Oldberg N, Kass PH. (2018). Pharmacokinetics of intravenous flumetasone and effects on plasma hydrocortisone concentrations and inflammatory mediators in the horse. Equine Vet J, 51(2), 238-245. https://doi.org/10.1111/evj.13002

Publication

ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 51
Issue: 2
Pages: 238-245

Researcher Affiliations

Knych, H K
  • K.L. Maddy Equine Analytical Chemistry Laboratory, School of Veterinary Medicine, University of California, Davis, USA.
  • Department of Veterinary Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, USA.
Arthur, R M
  • School of Veterinary Medicine, University of California, Davis, USA.
McKemie, D S
  • K.L. Maddy Equine Analytical Chemistry Laboratory, School of Veterinary Medicine, University of California, Davis, USA.
Baden, R
  • K.L. Maddy Equine Analytical Chemistry Laboratory, School of Veterinary Medicine, University of California, Davis, USA.
Oldberg, N
  • K.L. Maddy Equine Analytical Chemistry Laboratory, School of Veterinary Medicine, University of California, Davis, USA.
Kass, P H
  • Department of Population Health and Reproduction, School of Veterinary Medicine, University of California, Davis, USA.

MeSH Terms

  • Animals
  • Area Under Curve
  • Biomarkers
  • Cytokines / genetics
  • Cytokines / metabolism
  • Flumethasone / blood
  • Flumethasone / pharmacokinetics
  • Flumethasone / pharmacology
  • Gene Expression Regulation / drug effects
  • Glucocorticoids / blood
  • Glucocorticoids / pharmacokinetics
  • Half-Life
  • Horses / blood
  • Horses / physiology
  • Hydrocortisone / blood
  • Inflammation / metabolism
  • Inflammation / veterinary

Grant Funding

  • California Horse Racing Board

Citations

This article has been cited 3 times.
  1. Tou K, Cawley A, Bowen C, Bishop DP, Fu S. Towards Non-Targeted Screening of Lipid Biomarkers for Improved Equine Anti-Doping. Molecules 2022 Dec 30;28(1).
    doi: 10.3390/molecules28010312pubmed: 36615506google scholar: lookup
  2. Tou K, Cawley A, Bowen C, Sornalingam K, Fu S. Measurements of hydrocortisone and cortisone for longitudinal profiling of equine plasma by liquid chromatography-tandem mass spectrometry. Drug Test Anal 2022 May;14(5):943-952.
    doi: 10.1002/dta.3244pubmed: 35195373google scholar: lookup
  3. Knych HK. Administration Studies in Equine Antidoping Research: Designing Scientific Investigations to Effectively Direct Medication Control in Racehorses. Drug Test Anal 2025 Sep;17(9):1560-1566.
    doi: 10.1002/dta.3857pubmed: 39876751google scholar: lookup